STAR - Strides Pharma Science

Strides Pharma Science

STAR · Pharma > Pharmaceuticals & Drugs · Chairman: Arun Kumar · MD: R Ananthanarayanan · Listing date: Feb. 2, 2000 · Employees: 2390 · Bangalore · http://www.strides.com

Stock Price vs Company Growth

1.1%

11.7%

19.7%

33.9%

22.2%

83.3%

7.1%

10y

1.2%

all

12.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,157 1.1%

790

1,174

Company Overview

Sales

4,726 Cr

Growth: 8.3%

Profit after Tax

511 Cr

Growth: 28.7%

Mid Cap

10,666 Cr

P/E: 20.8x

Industry P/E: 30.4x

Fundamentals

Sales (Cr)	₹ 4,726
Growth	8.3%
EBITDA	19.1%
P/S	2.2x
Dividend	0.4%
P/E	20.8x
Book Value	₹ 10
PEG Ratio	2.4x
ROE	554.9%
P/B	N/A

Shareholding Pattern

Institutions

Sbi Long Term Equity Fund

6.67 %

Aditya Birla Sun Life Trustee Private Limited

6.5 %

Life Insurance Corporation Of India P & Gs Fund

4.61 %

Route One Offshore Master Fund, L.P.

4.46 %

Route One Fund I, L.P.

2.99 %

Promoters

Pronomz Ventures Llp

18.37 %

Arun Kumar Pillai

1.54 %

K R Ravishankar

1.4 %

Karuna Business Solutions Llp

1.36 %

Shasun Leasing And Finance (P) Limited

1.12 %

Others

Increase Decrease No change

Company Profile Detailed

The company is a global pharmaceutical company that develops, manufactures, and markets a wide range of high-quality, affordable generic medicines. The company’s diverse portfolio spans complex generics across multiple dosage forms including tablets, hard capsules, sachets, liquids, nasal sprays, topicals, and controlled substances. With its agile R&D, end-to-end integration, and a strong global distribution network, the company brings differentiated products to market across the U.S.

Belongs to (12 Indices) view more

Investors (183)

credit.s...

dsp.blac...

sbi.magn...

Followers (10)

chetan

damerla

swaroop